Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
iShares U.S. Healthcare ETF(IYH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for IYH
10/23/2026: IYH (3-star) is a STRONG-BUY. BUY for 104 days. Simulated Profits (19.32%). Updated daily EoD!
The iShares U.S. Healthcare ETF (IYH) provides diversified exposure to U.S.-based healthcare companies, spanning pharmaceuticals, biotechnology, and medical services. Its primary strength lies in its solid issuer backing by BlackRock, efficient index tracking, and broad industry representation. It is well-suited for long-term investors aiming to tilt their portfolios toward a defensive, innovation-driven sector. Key risks include industry-specific regulatory and drug-pricing policy changes, as well as concentration risk inherent in sector-focused funds. Investors should monitor healthcare legislation and sector innovation trends as primary factors influencing performance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The inclusion of biotechnology and innovation-led firms provides growth exposure within a defensive sector. |
| Momentum investor | Strong fit while signal remains positive | Momentum traders may find opportunities when healthcare leads broad market trends during economic volatility. |
| Value investor | Strong fit | Many large-cap pharmaceutical holdings are often categorized as value stocks with consistent earnings and dividends. |
| Dividend/Income investor | Strong fit | The portfolio includes established healthcare companies that historically provide reliable dividend income. |
| Low-risk investor | Strong fit | Healthcare is generally considered a defensive sector, often showing resilience during broader market downturns. |
Investor Profile
Ideal Investor Profile
Investors seeking targeted exposure to the U.S. healthcare sector for long-term growth or defensive portfolio balancing.
Suitability
Best suited for long-term investors looking for a core sector holding rather than short-term tactical traders.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | Medium | While defensive, biotech sub-sectors can introduce significant price swings into the portfolio. |
| Market risk | Medium | The ETF is subject to general equity market fluctuations despite its defensive sector nature. |
| Concentration | Medium / high | Being sector-specific, the fund lacks the broader diversification of a total market index. |
| Tracking/expense | Low | Low tracking error and reasonable expense ratios minimize structural performance drag. |
| Liquidity | Low | High trading volume in the ETF and its underlying stocks ensures easy execution. |
| Business/sector quality | Low / none | The sector benefits from inelastic demand for healthcare services and products. |
Risk Analysis
Volatility
IYH exhibits moderate volatility typical of a sector fund, influenced heavily by the biotech and pharma components.
Market Risk
The fund is inherently linked to U.S. healthcare policy and systemic industry trends, which can move independently of the broader S&P 500.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Pharmaceuticals | 32 | Provides exposure to major drug manufacturers that drive the healthcare industry's revenue. |
| Sector | Biotechnology | 28 | Offers growth potential through research-intensive firms developing next-generation medical treatments. |
| Sector | Health Care Equipment | 22 | Includes companies creating essential medical devices and diagnostic technology. |
| Sector | Managed Health Care | 18 | Includes insurance and service providers that form the backbone of the healthcare delivery system. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type ETF | Historic Profit 47.17% | Avg. Invested days 93 | Today’s Advisory Strong Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  5.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.